Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast
Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.
This is the core new event that explains the stock's surge and future growth outlook.
Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.
It shows the financial health behind the stock move and supports the bullish case.
Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.
It explains the strategic transformation that is driving new orders and investor enthusiasm.
Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.
It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.